This inventor holds 1 USPTO granted patent. Top assignee: Xintela Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Moustafa Elmasry: Innovator in Stem Cell Therapy
Introduction
Moustafa Elmasry is a prominent inventor based in Linkoping, Sweden. He has made significant contributions to the field of regenerative medicine, particularly in the treatment of skin defects. His innovative approach utilizes mesenchymal stem cells to enhance healing processes.
Latest Patents
Moustafa Elmasry holds a patent for "Mesenchymal stem cells for use in the treatment of skin defects." This invention relates to therapeutics and methods for treating skin defects using compositions comprising integrin α10-selected Mesenchymal Stem Cells (MSCs). The patent outlines integrin α10-selected MSC populations and culture conditions that improve cell viability, paracrine activity, and regenerative function when administered to damaged skin tissue. The compositions are designed to promote wound healing, modulate inflammatory responses, and support re-epithelialization. Additionally, the patent provides dosing parameters and administration routes suitable for enhancing healing outcomes in both acute and chronic skin defects. Moustafa Elmasry has 1 patent to his name.
Career Highlights
Moustafa Elmasry is associated with Xintela AB, a company focused on developing innovative stem cell therapies. His work at Xintela has positioned him as a key player in the advancement of regenerative medicine. His research and inventions have the potential to significantly impact the treatment of skin injuries and defects.
Collaborations
Moustafa has collaborated with notable colleagues, including Folke Sjöberg and Hooi Ching Lim. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of stem cell therapy.
Conclusion
Moustafa Elmasry is a visionary inventor whose work in mesenchymal stem cell therapy is paving the way for new treatments in regenerative medicine. His contributions are vital for improving healing outcomes in skin defects, showcasing the importance of innovation in healthcare.